Clinical study of pet/ct in location of refractory pre-operative epileptic focus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032559

Enrollment

Unknown

Registered

2020-05-02

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory epilepsy

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinically, if more than 2 antiepileptic drugs (antiepileptic drugs,aeds) are systematically applied, the drug reaches an effective concentration in vivo, and is observed for at least 2 years, the seizure is still not effectively controlled (with seizures every month) called refractory epilepsy.

Exclusion criteria

Exclusion criteria: 1. Patients without brain MR imaging and EEG monitoring; 2. Patients who stopped taking medicine or did not take medicine regularly during the follow-up period; 3. Patients younger than 18 or older than 80 years. 4. Patients who are unable to cooperate or refuse corresponding imaging or EEG monitoring. 5. Epilepsy caused by degenerative diseases and metabolic diseases, benign focal epilepsy, severe mental disorders caused by non epilepsy, mental regression, etc.

Design outcomes

Primary

Measure	Time frame
Frequency of seizures;	—

Countries

China

Contacts

Public ContactAihua Wang

The First Affiliated Hospital of Shandong First Medical University

0052@sdhospital.com.cn+86 13791120819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026